🔎 Trials Near Me

Home › Kanser sa Pancreas › California › Sacramento

Pag-aaral pangklinika para sa Kanser sa Pancreas sa Sacramento, CA

Isang pag-aaral para sa Kanser sa Pancreas ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Sacramento. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Nagre-recruitPhase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05372614

Distance-Based Exercise to Preserve Function and Prevent Disability

Nagre-recruit
  • Kaiser Permanente-South Sacramento, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07059884

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

Nagre-recruitPhase 3
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07252232

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2
  • UC Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Nagre-recruitObservasyonal na pag-aaral
  • University of California Davis Comprehensive Cancer Center, Sacramento
Edad 50 hanggang 75 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT04239573

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Nagre-recruitPhase 1/2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT04172532

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Nagre-recruitPhase 3
  • Sutter Medical Center Sacramento, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06958328

Pancreatic Cancer Early Detection Consortium

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • UC Davis, Sacramento
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT04970056

TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma

Nagre-recruitPhase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT07189195

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Nagre-recruitPhase 1
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT06040541

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Nagre-recruitPhase 3
  • Mercy Cancer Center - Sacramento, Sacramento
  • Sutter Medical Center Sacramento, Sacramento
  • Sutter Davis Hospital, Davis · 14 mi ang layo
  • at 1 pa
Edad 18 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT06998940

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Nagre-recruitPhase 1
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 15, 2025 · NCT04429542

Pag-aaral para sa Kanser sa Pancreas sa ibang lungsod

Iba pang pag-aaral sa Sacramento

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.